ORSI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 93
EU - Europa 67
AS - Asia 13
Continente sconosciuto - Info sul continente non disponibili 1
Totale 174
Nazione #
US - Stati Uniti d'America 93
SE - Svezia 33
IT - Italia 26
CN - Cina 9
DE - Germania 4
IN - India 4
IE - Irlanda 3
EU - Europa 1
RU - Federazione Russa 1
Totale 174
Città #
Ashburn 15
Milan 11
New York 10
Shanghai 9
Lawrence 7
Princeton 7
Carlsbad 5
Seattle 4
Dublin 3
Hyderabad 3
Rome 3
Berlin 2
Cuneo 2
Frankfurt am Main 2
Modena 2
Reggio Emilia 2
San Maurizio Canavese 2
Turin 2
Brescia 1
Pune 1
St Petersburg 1
Washington 1
Totale 95
Nome #
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 18
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 16
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 15
Extensive molecular reclassification: new perspectives in small bowel adenocarcinoma? 15
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey 14
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 12
The impact of nutritional status on pancreatic cancer therapy 12
Cyclophosphamide maintenance to extend combination chemotherapy-free interval in metastatic pancreatic ductal adenocarcinoma 11
Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variants 11
Epidemiology and geographic distribution of BRCA1-2 and DNA Damage response genes pathogenic variants in pancreatic ductal adenocarcinoma patients 11
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 10
Pancreatic cancer: still a cold case? 9
Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples 9
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma 9
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 9
Is the Delphi's Oracle Pertinent to Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma? 7
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes 6
Lessons and open questions in borderline resectable pancreatic cancer 6
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv) 6
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 5
Totale 211
Categoria #
all - tutte 2.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.286


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20229 0 0 0 0 0 0 0 5 3 0 0 1
2022/202369 14 11 5 0 1 16 4 10 2 0 6 0
2023/2024133 13 9 12 31 21 18 5 15 4 5 0 0
Totale 211